The inhibition of ABCB1/MDR1 or ABCG2/BCRP enables doxorubicin to eliminate liver cancer stem cells

The inhibition of ABCB1/MDR1 or ABCG2/BCRP enables doxorubicin to eliminate liver cancer stem cells

Abstract Two ATP-binding cassette transporters, ABCB1/MDR1 and ABCG2/BCRP, are considered the most critical determinants for chemoresistance in hepatocellular carcinoma. However, their roles in the chemoresistance in liver cancer stem cells remain elusive. Here we explored the role of inhibition of...

Full description

Bibliographic Details
Main Authors:	Wang Yin, Dongxi Xiang, Tao Wang, Yumei Zhang, Cuong V. Pham, Shufeng Zhou, Guoqin Jiang, Yingchun Hou, Yimin Zhu, Yinglu Han, Liang Qiao, Phuong H.-L. Tran, Wei Duan
Format:	Article
Language:	English
Published:	Nature Portfolio 2021-05-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-021-89931-9

Similar Items

Hedgehog Pathway Inhibitor HhAntag691 Is a Potent Inhibitor of ABCG2/BCRP and ABCB1/Pgp
by: Yimao Zhang, et al.
Published: (2009-01-01)

P-Glycoprotein (ABCB1/MDR1) and BCRP (ABCG2) Limit Brain Accumulation and Cytochrome P450-3A (CYP3A) Restricts Oral Exposure of the RET Inhibitor Selpercatinib (RETEVMO)
by: Yaogeng Wang, et al.
Published: (2021-10-01)

Extra-renal elimination of uric acid via intestinal efflux transporter BCRP/ABCG2.
by: Atsushi Hosomi, et al.
Published: (2012-01-01)

Chicken xenobiotic receptor upregulates the BCRP/ABCG2 transporter
by: Ziyong Xu, et al.
Published: (2023-01-01)

Karanjin interferes with ABCB1, ABCC1, and ABCG2
by: Martin Michaelis, et al.
Published: (2014-03-01)

Expression of ABCG2 (BCRP) in mouse models with enhanced erythropoiesis
by: Gladys Oluyemisi Latunde-Dada, et al.
Published: (2014-06-01)

BCRP/ABCG2 inhibition sensitizes hepatocellular carcinoma cells to sorafenib.
by: Wei-Chien Huang, et al.
Published: (2013-01-01)

CORRELATION BETWEEN CHEMOTHERAPY RESPONSE AND EXPRESSION PROFILES OF TRANSMEMBRANE PROTEINS: P-GLYCOPROTEIN (ABCB1), MRP2 (ABCC2), BCRP (ABCG2) IN PATIENTS WITH INVASIVE BREAST CANCER
by: К. Yu. Khristenko, et al.
Published: (2016-10-01)

Gene and functional up-regulation of the BCRP/ABCG2 transporter in hepatocellular carcinoma
by: Sukowati Caecilia HC, et al.
Published: (2012-11-01)

Effects of α-adrenoceptor antagonists on ABCG2/BCRP-mediated resistance and transport.
by: Kohji Takara, et al.
Published: (2012-01-01)

Development of precision medicine approaches based on inter-individual variability of BCRP/ABCG2
by: Liming Chen, et al.
Published: (2019-07-01)

Effect of ABCG2/BCRP Expression on Efflux and Uptake of Gefitinib in NSCLC Cell Lines.
by: Maricla Galetti, et al.
Published: (2015-01-01)

In silico prediction of inhibition of promiscuous breast cancer resistance protein (BCRP/ABCG2).
by: Yi-Lung Ding, et al.
Published: (2014-01-01)

The MDR1/ABCB1 gene rs1045642 polymorphism in colorectal cancer
by: Beata Mrozikiewicz-Rakowska, et al.
Published: (2019-12-01)

ABCG5 and ABCG8 require MDR2 for secretion of cholesterol into bile
by: Silvia Langheim, et al.
Published: (2005-08-01)

ABCB1 and ABCG2 Together Limit the Distribution of ABCB1/ABCG2 Substrates to the Human Retina and the ABCG2 Single Nucleotide Polymorphism Q141K (c.421C> A) May Lead to Increased Drug Exposure
by: Myriam El Biali, et al.
Published: (2021-06-01)

Improved Brain Penetration and Antitumor Efficacy of Temozolomide by Inhibition of ABCB1 and ABCG2
by: Mark C. de Gooijer, et al.
Published: (2018-07-01)

Co-administration of MDR1 and BCRP or EGFR/PI3K inhibitors overcomes lenvatinib resistance in hepatocellular carcinoma
by: Dawei Sun, et al.
Published: (2022-09-01)

Evaluation of mRNA Expression Profile of ABCG2/BCRP in Childhood Acute Lymphoblastic Leukemia
by: M Entezar-e-Ghaem, et al.
Published: (2013-12-01)

Modulating drug resistance by targeting BCRP/ABCG2 using retrovirus-mediated RNA interference.
by: Ni Xie, et al.
Published: (2014-01-01)

Novel Sigma-2 receptor ligand A011 overcomes MDR in adriamycin-resistant human breast cancer cells by modulating ABCB1 and ABCG2 transporter function
by: Zhanwei Zeng, et al.
Published: (2022-08-01)

Poziotinib Inhibits the Efflux Activity of the ABCB1 and ABCG2 Transporters and the Expression of the ABCG2 Transporter Protein in Multidrug Resistant Colon Cancer Cells
by: Yongchao Zhang, et al.
Published: (2020-11-01)

Extracellular Vesicles as Surrogates for the Regulation of the Drug Transporters ABCC2 (MRP2) and ABCG2 (BCRP)
by: Juan Pablo Rigalli, et al.
Published: (2024-04-01)

Correction: Modulating Drug Resistance by Targeting BCRP/ABCG2 Using Retrovirus-Mediated RNA Interference
Published: (2014-01-01)

ABCG2/BCRP transport mechanism revealed through kinetically excited targeted molecular dynamics simulations
by: B. Dudas, et al.
Published: (2022-01-01)

Jump into a New Fold-A Homology Based Model for the ABCG2/BCRP Multidrug Transporter.
by: Laura László, et al.
Published: (2016-01-01)

Interactions of ABCG2 (BCRP) with epidermal growth factor receptor kinase inhibitors developed for molecular imaging
by: Israa eAbdelrahman, et al.
Published: (2014-11-01)

Super analgesia of intrathecal morphine may be related to ABCB1 (MDR1) gene polymorphism
by: Qin WJ, et al.
Published: (2018-07-01)

Sitravatinib Sensitizes ABCB1- and ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Drugs
by: Chung-Pu Wu, et al.
Published: (2020-01-01)

Inhibitors of ABCB1 and ABCG2 overcame resistance to topoisomerase inhibitors in small cell lung cancer
by: Miwako Omori, et al.
Published: (2022-08-01)

Rheumatoid Arthritis Disease Activity Is Determinant for ABCB1 and ABCG2 Drug-Efflux Transporters Function.
by: Yemil Atisha-Fregoso, et al.
Published: (2016-01-01)

Clinical Significance of ABCG2/BCRP Quantified by Fluorescent Nanoparticles in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
by: Hiroshi Tada, et al.
Published: (2023-04-01)

Human ABC transporter ABCG2/BCRP expression in chemoresistance: basic and clinical perspectives for molecular cancer therapeutics
by: Noguchi K, et al.
Published: (2014-02-01)

Elevated BCRP/ABCG2 expression confers acquired resistance to gefitinib in wild-type EGFR-expressing cells.
by: Yun-Ju Chen, et al.
Published: (2011-01-01)

NAT10‐mediated mRNA N4‐acetylcytidine modification of MDR1 and BCRP promotes breast cancer progression
by: Cui‐Cui Zhao, et al.
Published: (2024-04-01)

Brain Distribution of Dual ABCB1/ABCG2 Substrates Is Unaltered in a Beta-Amyloidosis Mouse Model
by: Thomas Wanek, et al.
Published: (2020-11-01)

Meta-Analysis of ABCG2 and ABCB1 Polymorphisms With Sunitinib-Induced Toxicity and Efficacy in Renal Cell Carcinoma
by: Fengjun Sun, et al.
Published: (2021-03-01)

A comprehensive investigation on common polymorphisms in the MDR1/ABCB1 transporter gene and susceptibility to colorectal cancer.
by: Daniele Campa, et al.
Published: (2012-01-01)

The Pyrazolo[3,4-d]pyrimidine Derivative, SCO-201, Reverses Multidrug Resistance Mediated by ABCG2/BCRP
by: Sophie E. B. Ambjørner, et al.
Published: (2020-03-01)

Inhibition of Autophagy Promotes the Elimination of Liver Cancer Stem Cells by CD133 Aptamer-Targeted Delivery of Doxorubicin
by: Wang Yin, et al.
Published: (2022-11-01)